Legal Opinion
Merck & Co. v. Teva Pharmaceuticals USA, Inc.
Court of Appeals for the Federal Circuit
Decided January 28, 2005No. 2004-1005PublishedCited by 220 opinions
1Opinion of the Court
GAJARSA, Circuit Judge.
Teva Pharmaceuticals USA, Inc. (“Teva”) appeals the final judgment of the United States District Court of Delaware, which, after a bench trial, found Merck & Co.’s (“Merck”) U.S. Patent No. 5,994,329 (issued Nov. 30, 1999) (“the ’329 patent”) *1366not invalid as anticipated or obvious. The district court further found the ’329 patent to be enforceable, and the ’329 patent claims 23 and 37 constructively infringed by Teva’s Abbreviated New Drug Application (“ANDA”) under 35 U.S.C. § 271(e)(2)(A) of the Hatch-Waxman Act. Merck & Co., Inc. v. Teva Pharms. USA, Inc., 288…
2Cases cited21 opinions
- United States v. United States Gypsum Co.Supreme Court of the United States · 1948
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- Vitronics Corporation v. Conceptronic, Inc.Court of Appeals for the Federal Circuit · 1996
- Cybor Corporation v. Fas Technologies, Inc., and Fastar Ltd., Defendants-CrossCourt of Appeals for the Federal Circuit · 1998
- Renishaw Plc v. Marposs Societa' Per Azioni and Marposs CorporationCourt of Appeals for the Federal Circuit · 1998
16 more not listed; retrieve them via the Exa API.
3Cited by220 opinions
- Apple Inc. v. Motorola, Inc.Court of Appeals for the Federal Circuit · 2014
- Wbip, LLC v. Kohler Co.Court of Appeals for the Federal Circuit · 2016
- Procter & Gamble Co. v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2009
- Ormco Corporation v. Align TechnologyCourt of Appeals for the Federal Circuit · 2006
- Honeywell International Inc. v. Universal Avionics Systems Corp.Court of Appeals for the Federal Circuit · 2007
215 more not listed; retrieve them via the Exa API.